HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Priapism secondary to chronic myeloid leukemia: value of initial treatment with cavernous lavage plus adjuvant methoxamine].

AbstractOBJECTIVE:
To report a case of priapism secondary to leukemia, with special reference to the initial treatment in the emergency services.
METHODS:
A 53-year-old male with chronic myeloid leukemia presented with prolonged involuntary painful erection of 12 hours' duration. The physical examination and particularly the cavernosal blood gas study, indicated low flow priapism. Punction-lavage of the corpora cavernosa was performed. Because complete response was not achieved with this procedure, adjuvant intracavernous methoxamine was administered.
RESULTS:
Complete detumescence was achieved after the third dose of methoxamine. There was no recurrence and erectile function was preserved.
CONCLUSIONS:
We underscore the utility of combined cavernous lavage + adjuvant alpha-1 adrenergic agonist as initial therapy in priapism with this special etiology.
AuthorsNicolás Alberto Cruz Guerra, Luis Clemente Ramos, Ana Linares Quevedo, Javier Sáenz Medina, Bernabé Pozo Mengual, Antonio Allona Almagro
JournalArchivos espanoles de urologia (Arch Esp Urol) Vol. 55 Issue 3 Pg. 320-1 (Apr 2002) ISSN: 0004-0614 [Print] Spain
Vernacular TitlePriapismo secundario a leucemia mieloide crónica: valor del tratamiento inicial con lavado cavernoso más metoxamina adyuvante.
PMID12068767 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Adrenergic alpha-Agonists
  • Methoxamine
Topics
  • Adrenergic alpha-Agonists (therapeutic use)
  • Chemotherapy, Adjuvant
  • Chronic Disease
  • Humans
  • Leukemia, Myeloid (complications)
  • Male
  • Methoxamine (therapeutic use)
  • Middle Aged
  • Priapism (etiology, therapy)
  • Therapeutic Irrigation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: